Pharmaceutical industry
Àwòrán tí AI ṣe
Grifols prepares stock listing for its US Biopharma business
Ti AI ṣe iroyin Àwòrán tí AI ṣe
Grifols' board has approved preparing a public offering (OPV) of a minority stake in its US Biopharma business to reduce debt and fund growth. The company will retain majority control and continue listing in Spain. Its ADRs surged up to 13% in after-hours trading.